Jinghua Lu Selected Research

Jinghua Lu Research Topics

Disease

6	Infections 10/2023 - 12/2008
6	Inflammation (Inflammations) 01/2023 - 03/2011
4	Neoplasms (Cancer) 01/2022 - 11/2015
3	Autoimmune Diseases (Autoimmune Disease) 11/2015 - 11/2011
2	Malaria 01/2021 - 12/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 07/2017
1	COVID-19 10/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2023
1	Pain (Aches) 05/2022
1	Necrosis 04/2022
1	Wounds and Injuries (Trauma) 04/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2022
1	Atherosclerosis 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Colitis 12/2021
1	Human Influenza (Influenza) 01/2021
1	Acute malaria 01/2021
1	Liver Diseases (Liver Disease) 01/2018
1	Liver Neoplasms (Liver Cancer) 07/2017
1	Bacterial Infections (Bacterial Infection) 01/2015
1	Amyloidosis 04/2014

Drug/Important Bio-Agent (IBA)

2	CanagliflozinIBA 01/2023 - 01/2022
2	Peptides (Polypeptides)IBA 01/2023 - 01/2022
2	Immunoglobulin G (IgG)IBA 01/2021 - 11/2011
2	AntibodiesIBA 01/2021 - 11/2012
2	Liposomes (Liposome)IBA 01/2018 - 07/2017
2	Glycyrrhetinic Acid (Po 12)IBA 01/2018 - 07/2017
1	Prothrombin (Factor II)IBA 10/2023
1	Thromboplastin (Tissue Factor)IBA 10/2023
1	Blood Coagulation Factors (Coagulation Factor)IBA 10/2023
1	FibrinIBA 10/2023
1	Thrombin FDA Link 10/2023
1	Serine Proteases (Serine Protease)IBA 10/2023
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 06/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Adenosine Monophosphate (AMP)IBA 01/2023
1	Celecoxib (Celebrex)FDA Link 01/2023
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2023
1	ferrostatin-1IBA 01/2023
1	S-methylisothiopseudouroniumIBA 01/2023
1	Therapeutic UsesIBA 05/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 04/2022
1	empagliflozinIBA 04/2022
1	Adenosine Triphosphate (ATP)IBA 04/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022
1	triphosphoric acid (triphosphate)IBA 04/2022
1	HLA-C Antigens (HLA-C)IBA 01/2022
1	InflammasomesIBA 01/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	PhenolsIBA 12/2021
1	Phenol (Carbolic Acid)FDA Link 12/2021
1	Coumaric AcidsIBA 12/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Nucleic AcidsIBA 12/2018
1	Proguanil (Paludrine)FDA Link 12/2018
1	Atovaquone (Mepron)FDA Link 12/2018
1	pyrimidineIBA 12/2018
1	AntigensIBA 11/2018
1	Fc Receptors (Fc Receptor)IBA 01/2018
1	TriterpenesIBA 07/2017
1	IgG Receptors (Fc gamma RI)IBA 01/2015
1	Polysaccharides (Glycans)IBA 01/2015
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 04/2014
1	Complement System Proteins (Complement)IBA 03/2011
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 12/2008
1	Serum Amyloid P-ComponentIBA 12/2008
1	C-Reactive ProteinIBA 12/2008

Therapy/Procedure

5	Therapeutics 06/2023 - 01/2018
2	Immunotherapy 01/2020 - 11/2015
1	Percutaneous Collagen Induction 05/2022
1	Electroacupuncture 05/2022
1	Oral Administration 12/2021